New Drug Target Found for COVID-19
A new potential drug target has been identified in SARS CoV-2 – the virus that causes COVID-19 – by scientists who say multiple drugs will likely be needed to respond to the pandemic.
Browsing: "Microbiology"
Gold-plated Nanocrystals Could Help Fight Multiple Sclerosis
Gold-plated nanocrystals could help rebuild nerves damaged by multiple sclerosis, according to a recent study.
New Coronavirus Protein Reveals Drug Target
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
Gallbladder May Promote Transmission of Common Hospital-Acquired Infection
A recent study has found that the gallbladder may play a crucial role in the transmission of a common infection found in hospital settings, according to findings published in Nature Communications.
‘Cluster Bomb’ Toxin from Cholera Shuts Down Inflammatory Response While Attacking Cells
Northwestern scientists have determined that a toxin secreted by Vibrio cholerae bacteria, the pathogen responsible for cholera, suppresses the body’s normal immune response.
Northwestern Faculty Help Local Student-Inventors Test Winning Concepts
Three Chicagoland high school students created the PeelTowel, a citrus peel-based, anti-microbial paper towel, and tested it in the laboratory of Alan Hauser, MD, PhD, vice chair of the Department of Microbiology-Immunology.
New Program Connects PhD Students With Clinicians
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
Study Explores How Pneumonia Strains Compete
A recent study has shed light on how different strains of bacteria compete to cause pneumonia, findings that could inform how to best prevent infection.
Therapeutic Toxins
Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.
Improving Immunotherapy for Chronic Viral Infections
Northwestern Medicine scientists have identified a novel strategy that could improve the efficacy of immunotherapy in treating chronic viral infections.